Invest in the best stock opportunities right now and every-time.
Start Systematic Stock Investing ...in less than a minute.
Worth Seeing!
Transform your wealth with Omega. Exclusive consultation awaits.Schedule Meeting!
Schedule Meeting!
Shalby is currently trading at Rs. 146.60, up by 8.10 points or 5.85% from its previous closing of Rs. 138.50 on the BSE.
The scrip opened at Rs. 139.35 and has touched a high and low of Rs. 146.60 and Rs. 139.35 respectively. So far 9015 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 214.00 on 10-Aug-2021 and a 52 week low of Rs. 96.05 on 19-Mar-2021.
Last one week high and low of the scrip stood at Rs. 147.50 and Rs. 138.00 respectively. The current market cap of the company is Rs. 1560.20 crore.
The promoters holding in the company stood at 74.02%, while Institutions and Non-Institutions held 3.83% and 22.15% respectively.
Shalby’s wholly-owned subsidiary company -- Mars Medical Devices, has received import license from Central Drugs Standard Control Organization, Ministry of Health and Family Welfare, Govt. of India, for import of medical devices for the Complete range of Joint replacement products i.e. Total Knee System, Total Hip System etc. from Shalby Advanced Technologies Inc. USA (Step-down subsidiary of the Company).
This development is fully in line with stated strategy to grow company’s orthopaedic implant business and establish company’s footprint in the medical device market in India. This is a big milestone achieved by the Shalby group in its journey to serve many more patients in India.
The synergies between the businesses are compelling and will bring in immediate benefits of sourcing USFDA approved quality implants into India across hospital group including franchise networks as well as build a brand of repute amongst orthopaedic surgeons in India through distribution channels. The company has performed more than 1,30,000 joint replacement surgeries so far and continues to be the leader in India and globally in terms of the volume of surgeries performed annually.
Shalby is a chain of Multi-specialty tertiary care hospitals based out of Ahmedabad. It has combined bed strength of more than 700 beds with its multispecialty hospitals across Gujarat and Goa.
| Company Name | CMP |
|---|---|
| Apollo Hospital Ent. | 7036.65 |
| Max Healthcare Inst | 1006.75 |
| Narayana Hrudayalay | 1249.35 |
| Aster DM Healthcare | 444.55 |
| Global Health | 1115.50 |
| View more.. | |
MoneyWorks4Me rating and ranking of funds for SIP is available to subscribers only. Moneyworks4Me is not a rating and ranking agency, however it is required that users have a way of selecting funds and building a Portfolio. The method used by it are described below to enable users to understand the logic behind the rating and ranking Subscriber will find more details on this in the various content made available from time to time. In case you need more please write to besafe@moneyworks4Me.com
MoneyWorks4Me rates and ranks mutual funds based on the following data-driven system:
Funds ranking in screeners: Performance Consistency and Quality are two parameters used for ranking funds for SIP. The ranking as follows GG, GO, GR, OG, OO, OR, RG, RO and RR.
With the same color-coded funds, the one with the higher Average 3-year rolling returns (over 5 to 10 years), the number that appears in the Performance tag, ranks higher.
Here is the summary:
The third tag Upside Potential is not relevant for SIP. It is relevant for lumpsum investments in Mutual Funds.
Make an informed decision for Stocks
Buy quality Stocks when they are available at reasonable prices and supported by an upward price trend and Sell when they are Overvalued using the Decizen Rating System. Covers 3500+ stocks
Download APP
